Abiopharma

New Form 144 - Centessa Pharmaceuticals plc Filed: 2025-06-24 AccNo: 0001969223-25-000467 Size: 6 KB

New Form 8-K - Emergent BioSolutions Inc. Filed: 2025-06-24 AccNo: 0001367644-25-000153 Size: 210 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 3 - Centessa Pharmaceuticals plc Filed: 2025-06-24 AccNo: 0001847903-25-000103 Size: 15 KB

New Form 144 - AGIOS PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001900772-25-000005 Size: 4 KB

New Form 424B3 - Scilex Holding Co Filed: 2025-06-24 AccNo: 0000950170-25-089449 Size: 65 KB

New Form 4 - ARVINAS, INC. Filed: 2025-06-24 AccNo: 0001655759-25-000109 Size: 4 KB

New Form 424B3 - Scilex Holding Co Filed: 2025-06-24 AccNo: 0000950170-25-089447 Size: 59 KB

New Form 144 - AGIOS PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001900772-25-000004 Size: 4 KB

New Form 144 - SOLENO THERAPEUTICS INC Filed: 2025-06-24 AccNo: 0001950047-25-004555 Size: 15 KB

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

New Form 424B3 - ReShape Lifesciences Inc. Filed: 2025-06-24 AccNo: 0001104659-25-062096 Size: 9 MB

New Form S-8 - DBV Technologies S.A. Filed: 2025-06-24 AccNo: 0001193125-25-145724 Size: 300 KB

New Form 8-K - Cytosorbents Corp Filed: 2025-06-24 AccNo: 0001104659-25-062097 Size: 260 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 424B3 - Scilex Holding Co Filed: 2025-06-24 AccNo: 0000950170-25-089446 Size: 66 KB

New Form 8-K - PUMA BIOTECHNOLOGY, INC. Filed: 2025-06-24 AccNo: 0001437749-25-021153 Size: 346 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits